TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $110,765 | +6.7% | 7,160 | +8.4% | 0.00% | +33.3% |
| Q2 2023 | $103,812 | +24.1% | 6,608 | +30.2% | 0.00% | 0.0% |
| Q1 2023 | $83,636 | +55.3% | 5,075 | +47.0% | 0.00% | +50.0% |
| Q4 2022 | $53,851 | -63.4% | 3,452 | -69.6% | 0.00% | -71.4% |
| Q3 2022 | $147,000 | -2.0% | 11,356 | +6.0% | 0.01% | 0.0% |
| Q2 2022 | $150,000 | +3.4% | 10,716 | +6.4% | 0.01% | +16.7% |
| Q1 2022 | $145,000 | +46.5% | 10,072 | +38.8% | 0.01% | +50.0% |
| Q4 2021 | $99,000 | +2.1% | 7,255 | +22.7% | 0.00% | 0.0% |
| Q3 2021 | $97,000 | +27.6% | 5,913 | +30.4% | 0.00% | +33.3% |
| Q2 2021 | $76,000 | -12.6% | 4,536 | -4.7% | 0.00% | -25.0% |
| Q1 2021 | $87,000 | +26.1% | 4,758 | +25.1% | 0.00% | 0.0% |
| Q4 2020 | $69,000 | -12.7% | 3,804 | -13.6% | 0.00% | -20.0% |
| Q3 2020 | $79,000 | -1.2% | 4,401 | -2.5% | 0.01% | 0.0% |
| Q2 2020 | $80,000 | +110.5% | 4,514 | +80.2% | 0.01% | +66.7% |
| Q1 2020 | $38,000 | -2.6% | 2,505 | +27.6% | 0.00% | 0.0% |
| Q4 2019 | $39,000 | +50.0% | 1,963 | +30.1% | 0.00% | +50.0% |
| Q3 2019 | $26,000 | +271.4% | 1,509 | +276.3% | 0.00% | +100.0% |
| Q2 2019 | $7,000 | -78.8% | 401 | -75.3% | 0.00% | -75.0% |
| Q1 2019 | $33,000 | – | 1,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |